Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Can processed meats fit into a healthy diet?

15

Apr 2026

Can processed meats fit into a healthy diet?

This perspective-style review argues that processed meats remain valuable sources of high-quality protein, essential amino acids, and bioavailable micronutrients despite concerns about sodium, fat, and chronic disease links. It also contends that much of the evidence tying processed meat to adverse health outcomes is observational and potentially confounded, while emphasizing the role of processing in safety, shelf life, and food security.

Are healthy foods really healthy? Nutrition researchers say context matters

15

Apr 2026

Are healthy foods really healthy? Nutrition researchers say context matters

This Clinical Nutrition opinion paper argues that nutrition research should stop asking whether a food is simply “healthy” and instead ask what it is being compared with. Because diets are compositional, the health effects of foods depend on the specific substitution, and the authors argue that causal inference and network meta-analysis can improve how evidence is interpreted.

Lower-protein toddler formula does not reduce BMI at age 2, trial finds

15

Apr 2026

Lower-protein toddler formula does not reduce BMI at age 2, trial finds

A large randomized trial in Germany and Spain found that lowering milk protein intake during the second year of life did not reduce BMI z-score at 24 months, though it did produce a temporary BMI reduction at 18 months. Lower protein intake also led to more stable weight and length trajectories, while higher protein intake pushed growth upward relative to WHO standards.

Ultra-processed foods linked to higher obesity risk in adolescents

15

Apr 2026

Ultra-processed foods linked to higher obesity risk in adolescents

Adolescents who consume more ultra-processed foods (UPFs) have significantly higher odds of being overweight or obese, according to a new systematic review and meta-analysis published in the open-access journal PLOS One by Mekuriaw Nibret Aweke of the University of Gondar, Ethiopia, and colleagues.

Gut-liver changes drive foodborne infection severity in fatty liver disease

15

Apr 2026

Gut-liver changes drive foodborne infection severity in fatty liver disease

A research team led by the University of California, Irvine's Joe C. Wen School of Population & Public Health has uncovered a critical biological link explaining why individuals with metabolic dysfunction–associated steatotic liver disease (MASLD), or fatty liver disease, face significantly worse outcomes from certain foodborne infections.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.